Sabine Ott serves as the Chief Commercial Officer at SmartCella Holding AB since March 2025. Prior to this role, Sabine held several pivotal positions, including Senior Vice President of Business Development and Licensing at Revvity from May 2023 to March 2025, following the acquisition of Sirion by Revvity. In a concurrent role at Horizon Discovery, also part of Revvity, from October 2021 to March 2025, Sabine focused on business development and licensing for PinPoint Base Editing technologies. Previously, Sabine had a long tenure at SIRION BIOTECH GmbH, leading business development and licensing efforts for gene and cell therapy from April 2016 to March 2025. Earlier roles include Head of Business Development at GeneWake GmbH, Managing Director of the Research Association ForZebRA, and various positions at MWG Biotech AG. Sabine's academic background includes a Master's and Doctorate in Biology/Genetics from the University of Konstanz, along with a Bachelor's in Biology from Ludwig-Maximilian University Munich.
This person is not in any teams
This person is not in any offices